BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 10239067)

  • 1. The McCarran-Ferguson Act's antitrust exemption for insurance: language, history and policy.
    Weller CD
    Duke Law J; 1978 May; (2):587-643. PubMed ID: 10239067
    [No Abstract]   [Full Text] [Related]  

  • 2. Group life & Health Insurance Co. v. Royal Drug Co.: the McCarran-Ferguson Act and Health Service Plans.
    Szabo DS
    Am J Law Med; 1980; 5(4):393-413. PubMed ID: 7377202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hammering back at the insurance industry.
    Tabas AM; Tolin SA
    J Patient Acc Manage; 1980 Jan; ():10-3. PubMed ID: 10245929
    [No Abstract]   [Full Text] [Related]  

  • 4. Health insurance litigation.
    Jaffe AH
    J Health Hosp Law; 1991 Aug; 24(8):233-9. PubMed ID: 10113000
    [No Abstract]   [Full Text] [Related]  

  • 5. Health Maintenance Organizations and the McCarran-Ferguson Act.
    Schmidt S
    Am J Law Med; 1982; 7(4):437-67. PubMed ID: 7102680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Federal antitrust exemption, state laws combine to protect insurers.
    Horty JF
    Mod Healthc; 1982 Feb; 12(2):129-30. PubMed ID: 10254275
    [No Abstract]   [Full Text] [Related]  

  • 7. Business of insurance and antitrust: some case history.
    Weissburg C; Waxman JM
    Rev Fed Am Hosp; 1981; 14(4):42-4. PubMed ID: 10252197
    [No Abstract]   [Full Text] [Related]  

  • 8. Health insurance industry shouldn't be exempt from antitrust laws.
    Goldberg LG; Greenberg W
    Healthspan; 1991 May; 8(5):3-9. PubMed ID: 10111989
    [No Abstract]   [Full Text] [Related]  

  • 9. Antitrust risks in health insurance, staff boycotts, and shared services.
    Bernstein AH
    Hospitals; 1980 Jul; 54(13):33-4,82. PubMed ID: 7390432
    [No Abstract]   [Full Text] [Related]  

  • 10. An antitrust exemption for commercial insurers? Answer: no.
    Goldberg LG; Greenberg W
    Rev Fed Am Hosp; 1984; 17(1):84, 87. PubMed ID: 10265081
    [No Abstract]   [Full Text] [Related]  

  • 11. "New" York state of mind.
    Smoller BM
    Md Med; 2009; 10(1):4. PubMed ID: 19388397
    [No Abstract]   [Full Text] [Related]  

  • 12. No future guarantees for self-insured plans.
    Feezor A
    Bus Health; 1987 Apr; 4(6):16-9. PubMed ID: 10281226
    [No Abstract]   [Full Text] [Related]  

  • 13. PAs take on the reimbursement bureaucracy.
    Stalker T; Joyner SL
    Physician Assist Health Pract; 1979 Dec; 3(12):36-8, 40, 42. PubMed ID: 10314497
    [No Abstract]   [Full Text] [Related]  

  • 14. ERISA preemption of state mandated-provider laws.
    McDonough RS
    Duke Law J; 1985 Dec; (6):1194-216. PubMed ID: 10276650
    [No Abstract]   [Full Text] [Related]  

  • 15. Retrospective appeals procedures.
    Henriksen GA
    Mich Hosp; 1980 Aug; 16(8):13-4, 20. PubMed ID: 10297928
    [No Abstract]   [Full Text] [Related]  

  • 16. Insurance companies and McCarran-Ferguson Act--the ADA position.
    Umeda GT
    Hawaii Dent J; 2009; 40(5):4-6, 11. PubMed ID: 20415093
    [No Abstract]   [Full Text] [Related]  

  • 17. Recent supreme court antitrust rulings in health care.
    Podell LB
    Am J Hosp Pharm; 1983 Apr; 40(4):639-41. PubMed ID: 6846375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hit govt. recovery of vet care cost.
    Fisher MJ
    Natl Underwrit Life Health; 1979 Sep; 83(38):2, 38. PubMed ID: 10243640
    [No Abstract]   [Full Text] [Related]  

  • 19. Third-party reimbursement programs--Are they immune from antitrust attack?
    Berg RN
    J Med Assoc Ga; 1978 Nov; 67(11):941-3. PubMed ID: 712270
    [No Abstract]   [Full Text] [Related]  

  • 20. Durenburger's finance subcommittee will foster more health competition.
    Simler SL
    Mod Healthc; 1981 Feb; 11(2):24. PubMed ID: 10250303
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.